Nutex Health Inc.
NUTX
$160.95
$4.162.65%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 267.80M | 243.99M | 211.79M | 257.62M | 78.80M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 267.80M | 243.99M | 211.79M | 257.62M | 78.80M |
| Cost of Revenue | 107.92M | 113.81M | 88.36M | 110.71M | 51.91M |
| Gross Profit | 159.88M | 130.17M | 123.43M | 146.91M | 26.89M |
| SG&A Expenses | 24.51M | 91.25M | 37.68M | 27.35M | 11.83M |
| Depreciation & Amortization | 5.00M | 5.25M | 5.09M | 5.28M | 4.97M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 137.44M | 210.31M | 131.13M | 143.34M | 68.71M |
| Operating Income | 130.37M | 33.68M | 80.66M | 114.27M | 10.09M |
| Income Before Tax | 123.94M | 23.73M | 71.22M | 108.65M | -2.58M |
| Income Tax Expenses | 27.14M | 7.59M | 20.41M | 9.15M | 4.59M |
| Earnings from Continuing Operations | 96.80M | 16.14M | 50.81M | 99.50M | -7.17M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -41.36M | -33.84M | -29.59M | -37.89M | -1.62M |
| Net Income | 55.44M | -17.70M | 21.22M | 61.61M | -8.79M |
| EBIT | 130.37M | 33.68M | 80.66M | 114.27M | 10.09M |
| EBITDA | 135.37M | 38.93M | 85.75M | 119.56M | 15.06M |
| EPS Basic | 8.27 | -2.95 | 3.74 | 11.81 | -1.72 |
| Normalized Basic EPS | 5.39 | -3.17 | 2.63 | 5.75 | -0.58 |
| EPS Diluted | 7.76 | -2.95 | 3.16 | 11.31 | -1.72 |
| Normalized Diluted EPS | 5.03 | -3.17 | 2.23 | 5.41 | -0.58 |
| Average Basic Shares Outstanding | 6.70M | 5.99M | 5.67M | 5.22M | 5.10M |
| Average Diluted Shares Outstanding | 7.18M | 5.99M | 6.70M | 5.55M | 5.10M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | 34.71% | -- | -- |